NEW YORK (GenomeWeb News) – Absorption Systems of Exton, Pa. has won a grant from the US Food and Drug Administration to continue developing its line of cell-based tests to measure drug interactions in humans, the company said today.

The $417,000 Phase II Small Business Innovation Research grant will fund the development of the CellPort Technologies suite of in vitro test systems. These tests are designed to monitor interactions of drugs with a class of proteins called drug transporters, which mediate drug disposition throughout the body.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.

Nov
14
Sponsored by
PerkinElmer

In these times of economic constraint and increasing research costs, shared resource cores have become a cost-effective and essential platform for researchers who seek to investigate complex translational research questions.